Article
Sofosbuvir protects human brain organoids against SARS-CoV-2
2020-05-31
Abstract excerpt
COVID-19 was rapidly declared a pandemic by the World Health Organization, only three months after the initial outbreak in Wuhan, China. Early clinical care mainly focused on respiratory illnesses. However, a variety of neurological manifestations in both adults and newborns are also emerging. To determine whether SARS-CoV-2 could target the human brain, we infected iPSC-derived human brain organoids. Our findings...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a329f020-6931-5f92-b2e4-dd0e26ea8834
- DOI
- 10.1101/2020.05.30.125856
